|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 85, 318-324, Copyright © 1984 by American College of Chest Physicians
ARTICLES |
G Konig, C Luderschmidt, C Hammer, BC Adelmann-Grill, O Braun-Falco and G Fruhmann
Lung involvement (LI) was studied by lung function (LF) in 101 scleroderma patients (circumscribed scleroderma, n = 17; progressive systemic scleroderma [PSS], n = 84; with the subtypes I, acroscleroderma [n = 19]; 2, proximal ascending scleroderma [n = 61]; 3, trunk scleroderma [n = 4]). Eighteen percent of morphea, 32 percent of type 1, 56 percent of type 2, and 75 percent of type 3 patients had impaired LF. The LI was more frequent (57 percent vs 45 percent) and more severe (20 percent vs 3 percent) in PSS with systemic inflammation (form A) compared to those without (form B). Elevated lymphocytes/neutrophils in bronchoalveolar lavage (BAL) were found associated with form A and severe LI. The LF of patients showing an inflammatory cell pattern in initial BAL (n = 3) worsened, whereas those with normal BAL findings (n = 4) did not. Collagenase activity in BAL was significantly elevated in those with elevated lymphocytes/neutrophils in lavage. Patients with type 2 or 3 of PSS, especially form A, carry a higher risk of developing severe LI than circumscribed scleroderma, type 1, or form B patients. Differential cell count and collagenase activity in BAL is correlated with active disease and provides prognostic information.
This article has been cited by other articles:
![]() |
U. B.S. Prakash Uncommon Causes of Cough: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 206S - 219S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lamblin, C. Bergoin, T. Saelens, and B. Wallaert Interstitial lung diseases in collagen vascular diseases Eur. Respir. J., July 1, 2001; 18(32_suppl): 69S - 80s. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. IMOKAWA, A. SATO, H. HAYAKAWA, M. KOTANI, T. URANO, and A. TAKADA Tissue Factor Expression and Fibrin Deposition in the Lungs of Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 631 - 636. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |